172@29@17@102!~!172@29@0@53!~!|news|business|earnings|aarti-drugs-consolidated-march-2020-net-sales-at-rs-449-64-crore-down-2-07-y-o-y-5281671.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : May 18, 2020 01:24 PM IST | Source: Moneycontrol.com

Aarti Drugs Consolidated March 2020 Net Sales at Rs 449.64 crore, down 2.07% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Aarti Drugs are:

Net Sales at Rs 449.64 crore in March 2020 down 2.07% from Rs. 459.14 crore in March 2019.

Quarterly Net Profit at Rs. 58.86 crore in March 2020 up 114.5% from Rs. 27.44 crore in March 2019.

Close

EBITDA stands at Rs. 72.30 crore in March 2020 up 18.72% from Rs. 60.90 crore in March 2019.

Aarti Drugs EPS has increased to Rs. 25.26 in March 2020 from Rs. 12.06 in March 2019.

Aarti Drugs shares closed at 863.35 on May 15, 2020 (NSE) and has given 64.42% returns over the last 6 months and 43.25% over the last 12 months.

Aarti Drugs
Consolidated Quarterly Resultsin Rs. Cr.
Mar'20Dec'19Mar'19
Net Sales/Income from operations449.64473.51459.14
Other Operating Income------
Total Income From Operations449.64473.51459.14
EXPENDITURE
Consumption of Raw Materials282.62278.98244.12
Purchase of Traded Goods26.4627.9212.59
Increase/Decrease in Stocks-25.903.3364.79
Power & Fuel------
Employees Cost18.6017.3416.45
Depreciation12.4912.3610.81
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses76.5478.4565.28
P/L Before Other Inc., Int., Excpt. Items & Tax58.8355.1345.10
Other Income0.980.254.99
P/L Before Int., Excpt. Items & Tax59.8155.3850.09
Interest7.478.3910.34
P/L Before Exceptional Items & Tax52.3446.9939.75
Exceptional Items8.38-3.91--
P/L Before Tax60.7243.0839.75
Tax1.8615.3012.31
P/L After Tax from Ordinary Activities58.8627.7827.44
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period58.8627.7827.44
Minority Interest------
Share Of P/L Of Associates------
Net P/L After M.I & Associates58.8627.7827.44
Equity Share Capital23.3023.3023.58
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS25.2611.9212.06
Diluted EPS25.2611.9212.06
EPS After Extra Ordinary
Basic EPS25.2611.9212.06
Diluted EPS25.2611.9212.06
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

First Published on May 18, 2020 01:22 pm
Sections